Advanced Oncotherapy (AVO) – Exercise of Warrants, Issue of Shares and Holdings in Company

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has today issued 2,000,000 new ordinary shares (“New Shares”) of 25 pence in the Company to PI-Capital LLC, pursuant to the exercise of 2,000,000 warrants at 27.5 pence per New Share.  The warrants were issued in 2012.   Following […]